GOG 3067

A phase 1/2 dose escalation and dose-expansion study of zn-c3 in combination with niraparib and zn-c3 monotherapy in subjects with platinum-resistant ovarian cancer
Status:

Open

Trial Type:

Contact:

Dr. Cara Mathews
cmathews@wihri.org